4.6 Review

Rising Interest in the Development of Metal Complexes in Cancer Immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

A Carbonic Anhydrase IX (CAIX)-Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti-Tumor Immunity

Xuxian Su et al.

Summary: The designed CA-Re photosensitizer can efficiently perform photodynamic therapy under hypoxic conditions and improve tumor immunogenicity through pyroptotic cell death, activating immune cells to ultimately eliminate tumors.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Engineering, Biomedical

Ruthenium complexes boost NK cell immunotherapy via sensitizing triple-negative breast cancer and shaping immuno-microenvironment

Qi Chen et al.

Summary: The study focuses on designing ruthenium (Ru) polypyridyl complexes to enhance NK cells immunotherapy. The RuPOP complex effectively regulates immune suppressors and target proteins in tumor cells, increasing their sensitivity to NK cells. The combination treatment induces ROS generation, activates apoptosis-related receptors, and enhances interactions between NK and tumor cells, leading to caspase 3-dependent apoptosis. Additionally, the treatment boosts NK cell infiltration and reduces MDSC's protumoral capability. This study provides insights for enhancing NK cells immunotherapy and developing more effective clinical treatment options.

BIOMATERIALS (2022)

Review Chemistry, Multidisciplinary

Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future

Sajal Sen et al.

Summary: Cancer is the second deadliest disease worldwide, and immunotherapy using immunogenic cell death (ICD) shows promise in overcoming treatment limitations. Metal-based complexes have been identified as potential ICD inducers. This review assesses the progress in this field and sets the stage for future advances.

CHEMICAL SOCIETY REVIEWS (2022)

Article Biochemistry & Molecular Biology

A [Pt(cis-1,3-diaminocycloalkane)Cl2] analog exhibits hallmarks typical of immunogenic cell death inducers in model cancer cells

Vojtech Novohradsky et al.

Summary: Platinum drugs are commonly used in cancer treatment, but there is active research in developing new metal-based drugs with different mechanisms. The combination of cytotoxic chemotherapy and immunotherapy has shown promising synergistic effects, while the development of metal-based drugs that exhibit cytostatic effects and induce immunogenic cell death is of interest for cancer treatment.

JOURNAL OF INORGANIC BIOCHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives

Kevin Schindler et al.

Summary: Organometallic compounds of rhenium, particularly its tri- and dicarbonyl complexes, have shown promising potential as anticancer and antibiotic drugs due to their ease of preparation, stability, and unique photophysical and luminescent properties. This review focuses on discussing the structural variations and in vitro efficacy of these complexes in the past seven years, with an initial emphasis on tricarbonyl complexes and a later discussion on the future prospects of dicarbonyl species in this field.

MOLECULES (2022)

Review Oncology

Connecting copper and cancer: from transition metal signalling to metalloplasia

Eva J. Ge et al.

Summary: Copper is a essential nutrient with both beneficial and toxic properties to cells. Recent progress in transition metal signaling has led to new connections between researchers from different disciplines, with potential for translating basic research into clinical therapies for diseases. The relationship between copper and cancer is particularly important, with opportunities for leveraging disease vulnerabilities through copper-dependent signaling pathways.

NATURE REVIEWS CANCER (2022)

Article Biotechnology & Applied Microbiology

Mitochondrial copper depletion suppresses triple-negative breast cancer in mice

Liyang Cui et al.

Summary: The research developed a mitochondria-targeted copper-depleting nanoparticle that effectively inhibited the growth of triple-negative breast cancer cells and improved survival rates in mouse models. By depriving copper within cancer cells, this approach induced metabolic changes and apoptosis, highlighting its potential clinical relevance.

NATURE BIOTECHNOLOGY (2021)

Article Chemistry, Multidisciplinary

An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer

Lili Wang et al.

Summary: The Ir1 iridium complex induces immunogenic cell death in non-small cell lung cancer cells, triggering an anti-tumor T-cell response and resulting in long-lasting anti-tumor immunity through the activation of ICD. Ir1 is the first Ir-based complex capable of developing an immunomodulatory response by inducing immunogenic cell death.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Review Chemistry, Physical

Bioengineering of nano metal-organic frameworks for cancer immunotherapy

Gaowei Chong et al.

Summary: Immunotherapy techniques have shown great success in specific cancer types but face challenges such as fatal side effects, dysfunctional tumor microenvironment, and low immune response rates. Nano metal-organic frameworks (nMOFs) are emerging as a promising solution to these problems, offering opportunities for vaccine delivery and tumor-microenvironment modulation.

NANO RESEARCH (2021)

Editorial Material Oncology

Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy

Prathyusha Konda et al.

Summary: A new class of ruthenium-based photosensitizers have been discovered to induce potent cytotoxicity and immunogenic cell death in melanoma cells when activated by NIR light, potentially establishing protective antitumor immunity.

ONCOIMMUNOLOGY (2021)

Review Engineering, Biomedical

Immune Checkpoint Inhibitor-Based Strategies for Synergistic Cancer Therapy

Mengying He et al.

Summary: Immune checkpoint blockade therapy has shown potential efficacy in various cancers, but its effectiveness is limited when used alone. Studies have demonstrated that combining ICBT with other treatment modalities such as chemotherapy, radiotherapy, and phototherapy can enhance therapeutic outcomes. However, there are still challenges and potential issues that need to be addressed in the research on ICBT-based synergistic therapies.

ADVANCED HEALTHCARE MATERIALS (2021)

Review Cell Biology

Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response

Alessandro Sacco et al.

Summary: New insights have been gained into the impact of iron metabolism within the tumor microenvironment on cancer development. Iron promotes the production of reactive oxygen species, which can trigger cell death or malignant transformation, affecting tumor immunosurveillance. The potential and controversies of using iron metabolism as a target for anticancer treatments are discussed, particularly in the context of hot and cold tumors.
Article Immunology

Capsaicin attenuates immunosuppression induced by chronic stress in BALB/C mice

J. M. Viveros-Paredes et al.

Summary: Capsaicin treatment enhances immune response, rescues stress-induced splenocyte apoptosis, modulates Th1 and Th2 cytokines while decreasing TGF-01, reduces corticosterone production, attenuates corticosterone-induced immunosuppression, and directly modulates cellular immunomodulation.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Oncology

Current Strategies for Tumor Photodynamic Therapy Combined With Immunotherapy

Jianfeng Hua et al.

Summary: Photodynamic therapy (PDT) and immunotherapy each have their own advantages and limitations, but their efficacy against cancer can be improved through combination strategies. By inducing immunogenic cell death or using immune adjuvants, inhibitors of immune suppression, and immune checkpoint blockade, the antitumor effects of PDT and immunotherapy can be enhanced.

FRONTIERS IN ONCOLOGY (2021)

Review Chemistry, Multidisciplinary

Recent Advances in Engineered Materials for Immunotherapy-Involved Combination Cancer Therapy

Jun-Long Liang et al.

Summary: Immunotherapy combined with other therapeutic modalities is an effective strategy to enhance cancer treatment outcomes. Recent research has focused on the combination of immunotherapy with chemotherapy, phototherapy, radiotherapy, etc., while also discussing critical challenges and future research directions.

ADVANCED MATERIALS (2021)

Review Oncology

Pyroptosis, a new bridge to tumor immunity

Lisha Li et al.

Summary: Pyroptosis is a type of programmed cell death that can activate the immune system to kill cancer cells, yet it may also promote tumor development by changing the immune microenvironment.

CANCER SCIENCE (2021)

Review Biochemistry & Molecular Biology

A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers

Safiye Akkin et al.

Summary: Variations in cancer treatment approaches exist globally, but cancer remains the second leading cause of death. Immunotherapy and nanotechnology may enhance the efficacy of cancer treatment.

MOLECULES (2021)

Review Immunology

The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment

Vladimir Mulens-Arias et al.

Summary: The synthesis and functionalization of iron oxide nanoparticles have sparked interest in studying them as theranostic agents, particularly in the field of cancer immunotherapy. Understanding the effects of IONPs on the immune system is crucial, as they may impact immune cell responses through various mechanisms. Furthermore, harnessing the properties of IONPs could lead to the development of innovative therapies for cancer treatment.

FRONTIERS IN IMMUNOLOGY (2021)

Article Chemistry, Inorganic & Nuclear

A photoactivated Ir(iii) complex targets cancer stem cells and induces secretion of damage-associated molecular patterns in melanoma cells characteristic of immunogenic cell death

Gloria Vigueras et al.

Summary: This study introduces octahedral Ir(iii) complexes based on a benzimidazole backbone with low toxicity and high phototoxicity for targeting and abrogating malignant cancer stem cells (CSCs) in melanoma cells. The complexes induce immunogenic cell death (ICD) by generating photoinduced ROS and may selectively target tumors in photochemotherapy.

INORGANIC CHEMISTRY FRONTIERS (2021)

Review Oncology

The rediscovery of platinum-based cancer therapy

Sven Rottenberg et al.

Summary: Platinum chemotherapy agents continue to be widely used in cancer treatment, with recent insights into DNA repair mechanisms providing valuable explanations for their success. The understanding of defective DNA repair in many cancers sheds new light on secondary drug resistance mechanisms.

NATURE REVIEWS CANCER (2021)

Review Chemistry, Multidisciplinary

New Designs for Phototherapeutic Transition Metal Complexes

Cinzia Imberti et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Article Chemistry, Multidisciplinary

A Photocaged, Water-Oxidizing, and Nucleolus-Targeted Pt(IV) Complex with a Distinct Anticancer Mechanism

Zhiqin Deng et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Article Chemistry, Multidisciplinary

PlatinER: A Highly Potent Anticancer Platinum(II) Complex that Induces Endoplasmic Reticulum Stress Driven Immunogenic Cell Death

Max Jing Rui Tham et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Article Medicine, Research & Experimental

Intratumoral Cancer Chemotherapy with a Carrier-Based Immunogenic Cell-Death Eliciting Platinum (IV) Agent

Chad Groer et al.

MOLECULAR PHARMACEUTICS (2020)

Review Chemistry, Multidisciplinary

Organic/inorganic nanocomposites for cancer immunotherapy

Mingqiang Hao et al.

MATERIALS CHEMISTRY FRONTIERS (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Chemistry, Multidisciplinary

Combining Nanomedicine and Immunotherapy

Yang Shi et al.

ACCOUNTS OF CHEMICAL RESEARCH (2019)

Article Chemistry, Multidisciplinary

Anticancer IrIII-Aspirin Conjugates for Enhanced Metabolic Immuno-Modulation and Mitochondrial Lifetime Imaging

Xiao-Wen Wu et al.

CHEMISTRY-A EUROPEAN JOURNAL (2019)

Review Chemistry, Inorganic & Nuclear

The clinical development of carboplatin - A personal perspective

Hilary Calvert

INORGANICA CHIMICA ACTA (2019)

Article Chemistry, Multidisciplinary

Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy

Qian Chen et al.

ADVANCED MATERIALS (2019)

Review Chemistry, Multidisciplinary

Metal Drugs and the Anticancer Immune Response

Bernhard Englinger et al.

CHEMICAL REVIEWS (2019)

Article Chemistry, Multidisciplinary

Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy

Jinggong Liu et al.

CHEMICAL COMMUNICATIONS (2019)

Review Chemistry, Inorganic & Nuclear

Cyclometalated iridium(III) complexes for life science

Chiara Caporale et al.

COORDINATION CHEMISTRY REVIEWS (2018)

Review Chemistry, Inorganic & Nuclear

The side effects of platinum-based chemotherapy drugs: a review for chemists

Rabbab Oun et al.

DALTON TRANSACTIONS (2018)

Article Chemistry, Medicinal

Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?

Sreekanth Thota et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Review Multidisciplinary Sciences

Cancer immunotherapy using checkpoint blockade

Antoni Ribas et al.

SCIENCE (2018)

Review Immunology

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

Viktor Fleming et al.

FRONTIERS IN IMMUNOLOGY (2018)

News Item Multidisciplinary Sciences

Cancer immunologists scoop medicine Nobel prize

Heidi Ledford et al.

NATURE (2018)

Article Chemistry, Inorganic & Nuclear

Redox-Active Metal Complexes for Anticancer Therapy

Pingyu Zhang et al.

EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells

Milos Arsenijevic et al.

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)

Review Biotechnology & Applied Microbiology

Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy

Licia Uccelli et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Review Chemistry, Multidisciplinary

The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials

Leli Zeng et al.

CHEMICAL SOCIETY REVIEWS (2017)

Article Biochemistry & Molecular Biology

Anticancer metal drugs and immunogenic cell death

Alessio Terenzi et al.

JOURNAL OF INORGANIC BIOCHEMISTRY (2016)

Article Chemistry, Multidisciplinary

Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes

Daniel Yuan Qiang Wong et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

Editorial Material Medicine, Research & Experimental

Cancer immunotherapy: harnessing the immune system to battle cancer

Yiping Yang

JOURNAL OF CLINICAL INVESTIGATION (2015)

Review Cell Biology

Microenvironmental regulation of therapeutic response in cancer

Florian Klemm et al.

TRENDS IN CELL BIOLOGY (2015)

Article Chemistry, Inorganic & Nuclear

A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds

Benoit Bertrand et al.

DALTON TRANSACTIONS (2014)

Review Pharmacology & Pharmacy

Cisplatin in cancer therapy: Molecular mechanisms of action

Shaloam Dasari et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Review Biotechnology & Applied Microbiology

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

Katrina J. Falkenberg et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Review Immunology

Immunogenic Cell Death in Cancer Therapy

Guido Kroemer et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)

News Item Multidisciplinary Sciences

Cancer Immunotherapy

Jennifer Couzin-Frankel

SCIENCE (2013)

Article Multidisciplinary Sciences

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Luc Pilotte et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Pharmacology & Pharmacy

Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs

Ute Jungwirth et al.

MOLECULAR PHARMACOLOGY (2012)

Review Pharmacology & Pharmacy

Recent advances in the study on capsaicinoids and capsinoids

Xiu-Ju Luo et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2011)

Article Medicine, Research & Experimental

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

W. Joost Lesterhuis et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Biochemistry & Molecular Biology

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

Petra Heffeter et al.

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

Immunogenic death of colon cancer cells treated with oxaliplatin

A. Tesniere et al.

ONCOGENE (2010)

Article Multidisciplinary Sciences

Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells

Rathindra N. Bose et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Oncology

Tumor microenvironment and immune escape

Soldano Ferrone et al.

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2007)

Review Medicine, Research & Experimental

Adoptive T cell therapy for cancer in the clinic

Carl H. June

JOURNAL OF CLINICAL INVESTIGATION (2007)

Review Oncology

Neoplastic fever: a neglected paraneoplastic syndrome

JA Zell et al.

SUPPORTIVE CARE IN CANCER (2005)

Article Oncology

FDA drug approval summaries: Oxaliplatin

A Ibrahim et al.

ONCOLOGIST (2004)

Review Cell Biology

MHC class I antigens, immune surveillance, and tumor immune escape

A Garcia-Lora et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2003)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.